Vimarsana
Biggest News Aggregation in the World

Page 3 - Delivery Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Delivery Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Delivery Technologies Today - Breaking & Trending Today

Meyos €2.3 million for improving lives of chronic kidney patients - Vimarsana News

Meyos €2.3 million for improving lives of chronic kidney patients

Medtech startup Metyos has secured €2.3 million in pre-seed funding to advance its mission of improving the lives of chronic kidney disease (CKD) patients worldwide.

Advancements in Insulin Drug and Delivery Technologies: A Focus on Syringes and Vials with BCC Research Analysis - Vimarsana News

Advancements in Insulin Drug and Delivery Technologies: A Focus on Syringes and Vials with BCC Research Analysis

"According to the latest BCC Research study, the demand for Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials is estimated to increase from $55.8 billion in 2023 to reach $88.9 billion by 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028."

Source: yahoo.com
One2Treat: can it transfrom clinical research? - Vimarsana News

One2Treat: can it transfrom clinical research?

Today (March 26) One2Treat, a progressive startup specializing in digital health solutions, has launched a forward-thinking approach aimed at tackling key challenges in the biopharma industry.

Cresset expands North American presence with new Boston site - Vimarsana News

Cresset expands North American presence with new Boston site

Greater integration is to take place between the US and UK following an expansion says Cresset, a provider of integrated in-silico solutions for drug discovery.

AION Labs' CombinAble.AI: AI-powered antibody design redefined - Vimarsana News

AION Labs' CombinAble.AI: AI-powered antibody design redefined

In a bid to reshape the landscape of targeted antibody design, AION a creative venture studio based in Israel has introduced CombinAble.AI.